Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standard vs Infusional Chemotherapy Before Surgery in Esophageal Cancer
NCT00041262Phase 3Unknown
- Sponsor
- Medical Research Council
- Start
- Nov 2004
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of epirubicin in esophageal adenocarcinoma (EAC), sponsored by Medical Research Council. Status: unknown.
02
Drugs
epirubicin
03
Conditions
esophageal adenocarcinoma (EAC)
Beyond the preview
Go deeper on NCT00041262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00041262.